US Patent Issued to INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), Sorbonne Universite, Universite Paris Cite, Assistance Publique-Hopitaux de Paris (APHP), Fondation Asile des Aveugles on March 31 for "Methods of determining whether a subject has or is at risk of having a central serous chorioretinopathy" (French Inventors)

ALEXANDRIA, Va., March 31 -- United States Patent no. 12,590,331, issued on March 31, was assigned to INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (Paris), Sorbonne Universite (Paris), Universite Paris Cite (Paris), Assistance Publique-Hopitaux de Paris (APHP) (Paris) and Fondation Asile des Aveugles (Lausanne, Switzerland).

"Methods of determining whether a subject has or is at risk of having a central serous chorioretinopathy" was invented by Francine Behar-Cohen (Paris) and Min Zhao (Paris).

According to the abstract* released by the U.S. Patent & Trademark Office: "Central Serous chorioretinopathy (CSCR) is primarily an ocular disease, affecting the choroid and the retinal pigment epithelium. To date, no systemic...